Drug spending could rise 6.1 percent annually by 2020, federal projections show
(By Ike Swetlitz for STAT) WASHINGTON — Spending on prescription drugs is expected to increase at an accelerating rate over
Read moreHealth Care Finance
National healthcare groups urge Congress to delay Medicaid disproportionate share hospital cuts
(By Kelly Gooch for Becker’s Hospital Review) The American Hospital Association, along with seven other national healthcare organizations, are calling on federal
Read moreWalmart drops price of virtual visits from $40 to $4
(By Emily Rappleye for Becker’s Hospital Review) Walmart is offering employees a 90 percent discount on telemedicine, dropping the price
Read more‘Everyone is at fault’: With insulin prices skyrocketing, there’s plenty of blame to go around
(By Nicholas Florko for STAT) WASHINGTON — Fifteen years ago, a patient with diabetes might have paid $175.57 for a
Read moreSeema Verma: Americans have the right to know their health care and hospital costs
(By Seema Verma for STAT) Americans are prolific shoppers, constantly on the lookout for the best price for top-quality products
Read moreCan California Beat The Federal Government In Lowering Drug Prices?
(By Samantha Young for Kaiser Health News) California Gov. Gavin Newsom says he’s done waiting for the federal government to
Read moreDrug-Price Debate Targets Pharmacy Benefit Managers
(By Michael Ollove for Stateline an initiative of The Pew Charitable Trusts) In the bipartisan drive to control prescription drug
Read moreTexans Can Appeal Surprise Medical Bills, But The Process Can Be Draining
(By Ashley Lopez, KUT, for Kaiser Health News) In Texas, a growing number of patients are turning to a little-known
Read moreMedicare, Medicaid keeping per-capita cost under control, study suggests
(By Morgan Haefner for Becker’s Hospital Review) Growth in private health plan spending is increasing more than growth in Medicare
Read moreOptumRx sets demands for drugmaker price reductions
(By Alia Paavola for Becker’s Hospital Review) OptumRx, UnitedHealth Group’s pharmacy benefit manager unit, reportedly sent a letter to pharmaceutical
Read more